glp 1 afib Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Glucagon-Like Peptide-1 Protects Against Atrial

Name: glp 1 afib Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Glucagon-Like Peptide-1 Protects Against Atrial
Brand: www.cleversources.com
SKU: 54609624938
Price: 29.47 USD
Availability: InStock
Rating: 4.4023 (16 reviews)

SKU: 54609624938

4.4

USD29.47 USD73.47

Pay in 4 interest-free payments of $7.37 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Glucagon Like Peptide 1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice ScienceDirect Impact of GLP 1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real World Data Analysis Circulation: Arrhythmia and Electrophysiology If you take a GLP 1 medication to help manage your weight or blood sugar and also have a heart rhythm condition called atrial fibrillation (Afib), a new study from UVA Health offers Association of glucagon like peptide 1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization Diabetology & Metabolic Syndrome Springer Nature Link

Store: www.cleversources.com · Domain: www.cleversources.com

Description

One of the most surprising findings was that the lowering in Afib risk remained even among patients who gained weight while taking GLP-1 medications

Tolhurst, G., Heffron, H., Lam, Y

In our clinic, we think about GLP-1 support across four pillars

Another promising direction involves dissolving microneedles, which completely degrade upon administration, eliminating the need for disposal and improving patient compliance